Evidence map›Paper›PMID 25427192›Full record

ArticlePloS one2014

Peptidoglycan from fermentation by-product triggers defense responses in grapevine.

Yang Chen, Taito Takeda, Yoshinao Aoki, Keiko Fujita, Shunji Suzuki, Daisuke Igarashi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yang ChenInstitute for Innovation, Ajinomoto Co., Inc., Kawasaki, Kanagawa, Japan.
Taito TakedaInstitute for Innovation, Ajinomoto Co., Inc., Kawasaki, Kanagawa, Japan.
Yoshinao AokiInstitute of Enology and Viticulture, University of Yamanashi, Kofu, Yamanashi, Japan.
Keiko FujitaInstitute of Enology and Viticulture, University of Yamanashi, Kofu, Yamanashi, Japan; Faculty of Life and Environmental Sciences, Prefectural University of Hiroshima, Shobara, Hiroshima, Japan.
Shunji SuzukiInstitute of Enology and Viticulture, University of Yamanashi, Kofu, Yamanashi, Japan.
Daisuke IgarashiInstitute for Innovation, Ajinomoto Co., Inc., Kawasaki, Kanagawa, Japan.
Ajinomoto (Japan) · JPUniversity of Yamanashi · JPPrefectural University of Hiroshima · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plants are constantly under attack from a variety of microorganisms, and rely on a series of complex detection and response systems to protect themselves from infection. Here, we found that a by-product of glutamate fermentation triggered defense responses in grapevine, increasing the expression of defense response genes in cultured cells, foliar chitinase activity, and resistance to infection by downy mildew in leaf explants. To identify the molecule that triggered this innate immunity, we fractionated and purified candidates extracted from Corynebacterium glutamicum, a bacterium used in the production of amino acids by fermentation. Using hydrolysis by lysozyme, a silkworm larva plasma detection system, and gel filtration analysis, we identified peptidoglycan as inducing the defense responses. Peptidoglycans of Escherichia coli, Bacillus subtilis, and Staphylococcus aureus also generated similar defensive responses.

Indexed as

Bacillus subtilisChitinasesComplex MixturesCorynebacterium glutamicumEscherichia coliFermentationGene Expression Regulation, PlantGlutamic AcidPeptidoglycanPeronosporaPlant DiseasesPlant ImmunityPlant LeavesPlant ProteinsStaphylococcus aureusVitisChitinasesComplex MixturesGlutamic AcidPeptidoglycanPlant Proteins

Identifiers

PMID25427192
PMCPMC4245132
OpenAlexW2053332555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.